HOOK&trade-NHS-SS-Biotin reacts with protein primary amines. Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.
HOOK&trade-NHS-SS-Biotin reacts with protein primary amines. Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.
HOOK&trade NHS-SS-Biotin reacts with protein primary amines.Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.
HOOK&trade NHS-SS-Biotin reacts with protein primary amines.Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.
HOOK&trade NHS-Biotin reacts with protein primary amines. Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.
HOOK&trade NHS-Biotin reacts with protein primary amines. Amines, lysine &epsilon-amines and N-terminal &alpha-amines, are the most abundant group in protein molecules and represent the most common target for biotinylation.
This EIA is based on a double antibody sandwich technique that is applicable to the quantification of both low molecular weight and high molecular weight polymers of adiponectin, but not adiponectin trimers.
This EIA is based on a double antibody sandwich technique that is applicable to the quantification of both low molecular weight and high molecular weight polymers of adiponectin, but not adiponectin trimers.
An inhibitor of PKB/Akt activity (IC50 = 10-50 µM) that inhibits insulin-stimulated glucose transport and intracellular protein translocation inhibits additional serine/threonine kinases including PKA (IC50 = ~20 µM), p90 S6 (IC50 = ~50
An inhibitor of PKB/Akt activity (IC50 = 10-50 µM) that inhibits insulin-stimulated glucose transport and intracellular protein translocation inhibits additional serine/threonine kinases including PKA (IC50 = ~20 µM), p90 S6 (IC50 = ~50
An inverse agonist of LRH-1 (IC<sub>50</sub> = 3.7 µM) with maximum efficacy of 64% repression inactive at the related SF1 transcriptional activator alters the expression of haptoglobin, SAA1, and SAA4, induces the death of ER negative
An inverse agonist of LRH-1 (IC<sub>50</sub> = 3.7 µM) with maximum efficacy of 64% repression inactive at the related SF1 transcriptional activator alters the expression of haptoglobin, SAA1, and SAA4, induces the death of ER negative